On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
We have now added a new section called the "Assay History List" to the "At A Gla...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...